Do you have the same question? Follow this Question
Mar 27, 2025 - 04:09 PM
We’ve provided several answers to questions related to Xtandi (Enzalutamide) , see some other helpful Q&A related to this product.
Question: What is the DrugBank identifier for this medication?
Answer: The DrugBank identifier is DB08899. This identifier provides access to a comprehensive database of drug information, useful for healthcare professionals.
Question: What is the protein binding percentage of this medication?
Answer: The protein binding percentage is 97-98%. High protein binding indicates that the drug stays in the bloodstream longer, affecting its duration of action and potential interactions.
Question: Is this medication FDA approved?
Answer: Yes, this medication is FDA approved. FDA approval means that the medication has been rigorously tested for safety and efficacy, providing confidence to users about its quality and effectiveness.
